So if we take into consideration all those that cover unis give...

So if we take into consideration all those that cover unis give target prices of 3 usd plus then I would hope that when the strategic investor comes in then valuation will be imho 2.50. If the stake being sold is 50 percent then we are out of all money troubles the dilution would then mean we would expect 1.25 share price. The shorts would exit which would cause upward pressure ( the off shore loan debacle has ruined squeeze possibility) and we could end up around 1.75 to 2.00. On top of this once all our affairs are sorted I am sure the abbvie deal will be announced. That's when it will start to really recover 2.50 to 3.00 usd. This equates to 68 cents a share uns . I think this is conservative and with our cashflow sorted and momentum once again positive then it will happy days and back slapping.